Beclometasone

MECHANISM OF ACTION

Beclomethasone works by binding to glucocorticoid receptors, which reduces the release of inflammatory chemicals. This suppresses swelling, redness, and irritation, helping prevent symptoms of asthma, allergies, and other inflammatory conditions.

PHARMACOKINETICS

Absorption

Beclomethasone is partially absorbed into the bloodstream when inhaled or sprayed into the nose, but most of its effect is local at the site of administration. Oral absorption is minimal, and the drug undergoes first-pass metabolism in the liver, which reduces systemic exposure and limits side effects.

Distribution

Beclomethasone is widely distributed in the body after absorption, but its effects are mostly local when used as an inhaler or nasal spray. Only a small amount reaches systemic circulation, and it binds moderately to plasma proteins, helping limit widespread side effects.

Metabolism

Beclomethasone is rapidly metabolized in the liver by enzymes into its active and inactive forms. This metabolism reduces systemic exposure, helping to limit side effects while allowing the drug to act locally at the lungs, nose, or skin.

Excretion

Beclomethasone and its metabolites are primarily excreted through the urine, with a smaller amount eliminated in the feces. Most of the drug is removed from the body after it is metabolized in the liver, limiting systemic accumulation.

PHARMACODYNAMICS

Beclomethasone is a corticosteroid that reduces inflammation and suppresses immune responses. It binds to glucocorticoid receptors, inhibiting the release of inflammatory mediators and preventing swelling, redness, and irritation in the airways, nasal passages, or skin, thereby controlling symptoms of asthma, allergies, and other inflammatory conditions

ADMINISTRATION

Beclomethasone is administered via inhalers, nasal sprays, or topical creams depending on the condition being treated. Inhalers deliver the drug directly to the lungs for asthma, nasal sprays target the nasal passages for allergies, and creams or ointments are applied to the skin for inflammatory skin conditions.

DOSAGE AND STRENGTH

Beclomethasone is available in inhalers, nasal sprays, and topical creams, with doses adjusted by age and condition. Inhalers typically range from 40–320 mcg twice daily, nasal sprays 42–84 mcg per nostril daily, and creams are applied 1–2 times a day as needed.

FOOD INTERACTIONS

Beclomethasone has no significant food interactions, so it can be taken with or without meals. However, patients should avoid grapefruit or grapefruit juice if taking oral corticosteroids, as it may affect metabolism, though this is less relevant for inhaled or nasal forms.

DRUG INTERACTIONS

Beclomethasone may interact with strong CYP3A4 inhibitors (like ketoconazole or ritonavir), which can increase its levels and risk of side effects. Concurrent use with other corticosteroids or immunosuppressants may also enhance systemic effects, so monitoring is recommended when combining these drugs.

CONTRAINDICATIONS

Beclomethasone is contraindicated in patients with known hypersensitivity to the drug or other corticosteroids. It should be used cautiously in untreated infections, as it can suppress the immune response and worsen infections.

SIDE EFFECTS

• Throat irritation

• Hoarseness

• Nasal dryness

• Mild cough

• Adrenal suppression

• Slowed growth in children

• Skin thinning 

TOXICITY

Beclomethasone toxicity is rare with standard inhaled, nasal, or topical use but can occur with high doses or prolonged therapy. Signs may include adrenal suppression, Cushing’s syndrome, slowed growth in children, osteoporosis, or immune suppression.